 | • レポートコード：QFJ1-6049 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、122ページ • 納品方法：Eメール（納期：3日） • 産業分類：医薬品 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査レポートでは、経皮薬物送達システムの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（フェンタニル、ニトログリセリン、エストラジオール、ニコチン、その他）、用途別市場規模（OTC、Rx）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・経皮薬物送達システムの市場動向 ・企業の競争状況、市場シェア ・経皮薬物送達システムの種類別市場規模と予測2016-2027（フェンタニル、ニトログリセリン、エストラジオール、ニコチン、その他） ・経皮薬物送達システムの用途別市場規模と予測2016-2027（OTC、Rx） ・経皮薬物送達システムの北米市場規模2016-2027（アメリカ、カナダ） ・経皮薬物送達システムの欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・経皮薬物送達システムのアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・経皮薬物送達システムの中南米市場規模2016-2027（メキシコ、ブラジル） ・経皮薬物送達システムの中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Hisamitsu、Mylan、GSK、Novartis、Teve(Actavis)、Johnson & Johnson、UCB、Teikoku Seiyaku、Bayer、Lingrui、Sanofi、Qizheng、Endo、Huarun 999、Haw Par、Nichiban、Mentholatum Company、Laboratoires Genevrier） ・結論 |
Transdermal Drug Delivery System is a medicated adhesive patch that is placed on the skin to deliver a specific dose of medication through the skin and into the bloodstream. Often, this promotes healing to an injured area of the body. An advantage of a transdermal drug delivery route over other types of medication delivery such as oral, topical, intravenous, intramuscular, etc. is that the patch provides a controlled release of the medication into the patient, usually through either a porous membrane covering a reservoir of medication or through body heat melting thin layers of medication embedded in the adhesive.
Market Analysis and Insights: Global Transdermal Drug Delivery Systems Market
The global Transdermal Drug Delivery Systems market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Transdermal Drug Delivery Systems market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Transdermal Drug Delivery Systems market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Transdermal Drug Delivery Systems market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Transdermal Drug Delivery Systems market.
Global Transdermal Drug Delivery Systems Scope and Market Size
Transdermal Drug Delivery Systems market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Transdermal Drug Delivery Systems market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Fentanyl
Nitroglycerin
Estradiol
Nicotine
Other
Segment by Application
OTC
Rx
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Hisamitsu
Mylan
GSK
Novartis
Teve(Actavis)
Johnson & Johnson
UCB
Teikoku Seiyaku
Bayer
Lingrui
Sanofi
Qizheng
Endo
Huarun 999
Haw Par
Nichiban
Mentholatum Company
Laboratoires Genevrier
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Transdermal Drug Delivery Systems Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Fentanyl
1.2.3 Nitroglycerin
1.2.4 Estradiol
1.2.5 Nicotine
1.2.6 Other
1.3 Market by Application
1.3.1 Global Transdermal Drug Delivery Systems Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 OTC
1.3.3 Rx
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Transdermal Drug Delivery Systems Market Perspective (2016-2027)
2.2 Transdermal Drug Delivery Systems Growth Trends by Regions
2.2.1 Transdermal Drug Delivery Systems Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Transdermal Drug Delivery Systems Historic Market Share by Regions (2016-2021)
2.2.3 Transdermal Drug Delivery Systems Forecasted Market Size by Regions (2022-2027)
2.3 Transdermal Drug Delivery Systems Industry Dynamic
2.3.1 Transdermal Drug Delivery Systems Market Trends
2.3.2 Transdermal Drug Delivery Systems Market Drivers
2.3.3 Transdermal Drug Delivery Systems Market Challenges
2.3.4 Transdermal Drug Delivery Systems Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Transdermal Drug Delivery Systems Players by Revenue
3.1.1 Global Top Transdermal Drug Delivery Systems Players by Revenue (2016-2021)
3.1.2 Global Transdermal Drug Delivery Systems Revenue Market Share by Players (2016-2021)
3.2 Global Transdermal Drug Delivery Systems Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Transdermal Drug Delivery Systems Revenue
3.4 Global Transdermal Drug Delivery Systems Market Concentration Ratio
3.4.1 Global Transdermal Drug Delivery Systems Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Transdermal Drug Delivery Systems Revenue in 2020
3.5 Transdermal Drug Delivery Systems Key Players Head office and Area Served
3.6 Key Players Transdermal Drug Delivery Systems Product Solution and Service
3.7 Date of Enter into Transdermal Drug Delivery Systems Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Transdermal Drug Delivery Systems Breakdown Data by Type
4.1 Global Transdermal Drug Delivery Systems Historic Market Size by Type (2016-2021)
4.2 Global Transdermal Drug Delivery Systems Forecasted Market Size by Type (2022-2027)
5 Transdermal Drug Delivery Systems Breakdown Data by Application
5.1 Global Transdermal Drug Delivery Systems Historic Market Size by Application (2016-2021)
5.2 Global Transdermal Drug Delivery Systems Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Transdermal Drug Delivery Systems Market Size (2016-2027)
6.2 North America Transdermal Drug Delivery Systems Market Size by Type
6.2.1 North America Transdermal Drug Delivery Systems Market Size by Type (2016-2021)
6.2.2 North America Transdermal Drug Delivery Systems Market Size by Type (2022-2027)
6.2.3 North America Transdermal Drug Delivery Systems Market Size by Type (2016-2027)
6.3 North America Transdermal Drug Delivery Systems Market Size by Application
6.3.1 North America Transdermal Drug Delivery Systems Market Size by Application (2016-2021)
6.3.2 North America Transdermal Drug Delivery Systems Market Size by Application (2022-2027)
6.3.3 North America Transdermal Drug Delivery Systems Market Size by Application (2016-2027)
6.4 North America Transdermal Drug Delivery Systems Market Size by Country
6.4.1 North America Transdermal Drug Delivery Systems Market Size by Country (2016-2021)
6.4.2 North America Transdermal Drug Delivery Systems Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Transdermal Drug Delivery Systems Market Size (2016-2027)
7.2 Europe Transdermal Drug Delivery Systems Market Size by Type
7.2.1 Europe Transdermal Drug Delivery Systems Market Size by Type (2016-2021)
7.2.2 Europe Transdermal Drug Delivery Systems Market Size by Type (2022-2027)
7.2.3 Europe Transdermal Drug Delivery Systems Market Size by Type (2016-2027)
7.3 Europe Transdermal Drug Delivery Systems Market Size by Application
7.3.1 Europe Transdermal Drug Delivery Systems Market Size by Application (2016-2021)
7.3.2 Europe Transdermal Drug Delivery Systems Market Size by Application (2022-2027)
7.3.3 Europe Transdermal Drug Delivery Systems Market Size by Application (2016-2027)
7.4 Europe Transdermal Drug Delivery Systems Market Size by Country
7.4.1 Europe Transdermal Drug Delivery Systems Market Size by Country (2016-2021)
7.4.2 Europe Transdermal Drug Delivery Systems Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Transdermal Drug Delivery Systems Market Size (2016-2027)
8.2 Asia-Pacific Transdermal Drug Delivery Systems Market Size by Type
8.2.1 Asia-Pacific Transdermal Drug Delivery Systems Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Transdermal Drug Delivery Systems Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Transdermal Drug Delivery Systems Market Size by Type (2016-2027)
8.3 Asia-Pacific Transdermal Drug Delivery Systems Market Size by Application
8.3.1 Asia-Pacific Transdermal Drug Delivery Systems Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Transdermal Drug Delivery Systems Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Transdermal Drug Delivery Systems Market Size by Application (2016-2027)
8.4 Asia-Pacific Transdermal Drug Delivery Systems Market Size by Region
8.4.1 Asia-Pacific Transdermal Drug Delivery Systems Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Transdermal Drug Delivery Systems Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Transdermal Drug Delivery Systems Market Size (2016-2027)
9.2 Latin America Transdermal Drug Delivery Systems Market Size by Type
9.2.1 Latin America Transdermal Drug Delivery Systems Market Size by Type (2016-2021)
9.2.2 Latin America Transdermal Drug Delivery Systems Market Size by Type (2022-2027)
9.2.3 Latin America Transdermal Drug Delivery Systems Market Size by Type (2016-2027)
9.3 Latin America Transdermal Drug Delivery Systems Market Size by Application
9.3.1 Latin America Transdermal Drug Delivery Systems Market Size by Application (2016-2021)
9.3.2 Latin America Transdermal Drug Delivery Systems Market Size by Application (2022-2027)
9.3.3 Latin America Transdermal Drug Delivery Systems Market Size by Application (2016-2027)
9.4 Latin America Transdermal Drug Delivery Systems Market Size by Country
9.4.1 Latin America Transdermal Drug Delivery Systems Market Size by Country (2016-2021)
9.4.2 Latin America Transdermal Drug Delivery Systems Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Transdermal Drug Delivery Systems Market Size (2016-2027)
10.2 Middle East & Africa Transdermal Drug Delivery Systems Market Size by Type
10.2.1 Middle East & Africa Transdermal Drug Delivery Systems Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Transdermal Drug Delivery Systems Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Transdermal Drug Delivery Systems Market Size by Type (2016-2027)
10.3 Middle East & Africa Transdermal Drug Delivery Systems Market Size by Application
10.3.1 Middle East & Africa Transdermal Drug Delivery Systems Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Transdermal Drug Delivery Systems Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Transdermal Drug Delivery Systems Market Size by Application (2016-2027)
10.4 Middle East & Africa Transdermal Drug Delivery Systems Market Size by Country
10.4.1 Middle East & Africa Transdermal Drug Delivery Systems Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Transdermal Drug Delivery Systems Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Hisamitsu
11.1.1 Hisamitsu Company Details
11.1.2 Hisamitsu Business Overview
11.1.3 Hisamitsu Transdermal Drug Delivery Systems Introduction
11.1.4 Hisamitsu Revenue in Transdermal Drug Delivery Systems Business (2016-2021)
11.1.5 Hisamitsu Recent Development
11.2 Mylan
11.2.1 Mylan Company Details
11.2.2 Mylan Business Overview
11.2.3 Mylan Transdermal Drug Delivery Systems Introduction
11.2.4 Mylan Revenue in Transdermal Drug Delivery Systems Business (2016-2021)
11.2.5 Mylan Recent Development
11.3 GSK
11.3.1 GSK Company Details
11.3.2 GSK Business Overview
11.3.3 GSK Transdermal Drug Delivery Systems Introduction
11.3.4 GSK Revenue in Transdermal Drug Delivery Systems Business (2016-2021)
11.3.5 GSK Recent Development
11.4 Novartis
11.4.1 Novartis Company Details
11.4.2 Novartis Business Overview
11.4.3 Novartis Transdermal Drug Delivery Systems Introduction
11.4.4 Novartis Revenue in Transdermal Drug Delivery Systems Business (2016-2021)
11.4.5 Novartis Recent Development
11.5 Teve(Actavis)
11.5.1 Teve(Actavis) Company Details
11.5.2 Teve(Actavis) Business Overview
11.5.3 Teve(Actavis) Transdermal Drug Delivery Systems Introduction
11.5.4 Teve(Actavis) Revenue in Transdermal Drug Delivery Systems Business (2016-2021)
11.5.5 Teve(Actavis) Recent Development
11.6 Johnson & Johnson
11.6.1 Johnson & Johnson Company Details
11.6.2 Johnson & Johnson Business Overview
11.6.3 Johnson & Johnson Transdermal Drug Delivery Systems Introduction
11.6.4 Johnson & Johnson Revenue in Transdermal Drug Delivery Systems Business (2016-2021)
11.6.5 Johnson & Johnson Recent Development
11.7 UCB
11.7.1 UCB Company Details
11.7.2 UCB Business Overview
11.7.3 UCB Transdermal Drug Delivery Systems Introduction
11.7.4 UCB Revenue in Transdermal Drug Delivery Systems Business (2016-2021)
11.7.5 UCB Recent Development
11.8 Teikoku Seiyaku
11.8.1 Teikoku Seiyaku Company Details
11.8.2 Teikoku Seiyaku Business Overview
11.8.3 Teikoku Seiyaku Transdermal Drug Delivery Systems Introduction
11.8.4 Teikoku Seiyaku Revenue in Transdermal Drug Delivery Systems Business (2016-2021)
11.8.5 Teikoku Seiyaku Recent Development
11.9 Bayer
11.9.1 Bayer Company Details
11.9.2 Bayer Business Overview
11.9.3 Bayer Transdermal Drug Delivery Systems Introduction
11.9.4 Bayer Revenue in Transdermal Drug Delivery Systems Business (2016-2021)
11.9.5 Bayer Recent Development
11.10 Lingrui
11.10.1 Lingrui Company Details
11.10.2 Lingrui Business Overview
11.10.3 Lingrui Transdermal Drug Delivery Systems Introduction
11.10.4 Lingrui Revenue in Transdermal Drug Delivery Systems Business (2016-2021)
11.10.5 Lingrui Recent Development
11.11 Sanofi
11.11.1 Sanofi Company Details
11.11.2 Sanofi Business Overview
11.11.3 Sanofi Transdermal Drug Delivery Systems Introduction
11.11.4 Sanofi Revenue in Transdermal Drug Delivery Systems Business (2016-2021)
11.11.5 Sanofi Recent Development
11.12 Qizheng
11.12.1 Qizheng Company Details
11.12.2 Qizheng Business Overview
11.12.3 Qizheng Transdermal Drug Delivery Systems Introduction
11.12.4 Qizheng Revenue in Transdermal Drug Delivery Systems Business (2016-2021)
11.12.5 Qizheng Recent Development
11.13 Endo
11.13.1 Endo Company Details
11.13.2 Endo Business Overview
11.13.3 Endo Transdermal Drug Delivery Systems Introduction
11.13.4 Endo Revenue in Transdermal Drug Delivery Systems Business (2016-2021)
11.13.5 Endo Recent Development
11.14 Huarun 999
11.14.1 Huarun 999 Company Details
11.14.2 Huarun 999 Business Overview
11.14.3 Huarun 999 Transdermal Drug Delivery Systems Introduction
11.14.4 Huarun 999 Revenue in Transdermal Drug Delivery Systems Business (2016-2021)
11.14.5 Huarun 999 Recent Development
11.15 Haw Par
11.15.1 Haw Par Company Details
11.15.2 Haw Par Business Overview
11.15.3 Haw Par Transdermal Drug Delivery Systems Introduction
11.15.4 Haw Par Revenue in Transdermal Drug Delivery Systems Business (2016-2021)
11.15.5 Haw Par Recent Development
11.16 Nichiban
11.16.1 Nichiban Company Details
11.16.2 Nichiban Business Overview
11.16.3 Nichiban Transdermal Drug Delivery Systems Introduction
11.16.4 Nichiban Revenue in Transdermal Drug Delivery Systems Business (2016-2021)
11.16.5 Nichiban Recent Development
11.17 Mentholatum Company
11.17.1 Mentholatum Company Company Details
11.17.2 Mentholatum Company Business Overview
11.17.3 Mentholatum Company Transdermal Drug Delivery Systems Introduction
11.17.4 Mentholatum Company Revenue in Transdermal Drug Delivery Systems Business (2016-2021)
11.17.5 Mentholatum Company Recent Development
11.18 Laboratoires Genevrier
11.18.1 Laboratoires Genevrier Company Details
11.18.2 Laboratoires Genevrier Business Overview
11.18.3 Laboratoires Genevrier Transdermal Drug Delivery Systems Introduction
11.18.4 Laboratoires Genevrier Revenue in Transdermal Drug Delivery Systems Business (2016-2021)
11.18.5 Laboratoires Genevrier Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Transdermal Drug Delivery Systems Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Fentanyl
Table 3. Key Players of Nitroglycerin
Table 4. Key Players of Estradiol
Table 5. Key Players of Nicotine
Table 6. Key Players of Other
Table 7. Global Transdermal Drug Delivery Systems Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Transdermal Drug Delivery Systems Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Transdermal Drug Delivery Systems Market Size by Regions (2016-2021) & (US$ Million)
Table 10. Global Transdermal Drug Delivery Systems Market Share by Regions (2016-2021)
Table 11. Global Transdermal Drug Delivery Systems Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 12. Global Transdermal Drug Delivery Systems Market Share by Regions (2022-2027)
Table 13. Transdermal Drug Delivery Systems Market Trends
Table 14. Transdermal Drug Delivery Systems Market Drivers
Table 15. Transdermal Drug Delivery Systems Market Challenges
Table 16. Transdermal Drug Delivery Systems Market Restraints
Table 17. Global Transdermal Drug Delivery Systems Revenue by Players (2016-2021) & (US$ Million)
Table 18. Global Transdermal Drug Delivery Systems Market Share by Players (2016-2021)
Table 19. Global Top Transdermal Drug Delivery Systems Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Transdermal Drug Delivery Systems as of 2020)
Table 20. Ranking of Global Top Transdermal Drug Delivery Systems Companies by Revenue (US$ Million) in 2020
Table 21. Global 5 Largest Players Market Share by Transdermal Drug Delivery Systems Revenue (CR5 and HHI) & (2016-2021)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Transdermal Drug Delivery Systems Product Solution and Service
Table 24. Date of Enter into Transdermal Drug Delivery Systems Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Transdermal Drug Delivery Systems Market Size by Type (2016-2021) (US$ Million)
Table 27. Global Transdermal Drug Delivery Systems Revenue Market Share by Type (2016-2021)
Table 28. Global Transdermal Drug Delivery Systems Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 29. Global Transdermal Drug Delivery Systems Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 30. Global Transdermal Drug Delivery Systems Market Size Share by Application (2016-2021) & (US$ Million)
Table 31. Global Transdermal Drug Delivery Systems Revenue Market Share by Application (2016-2021)
Table 32. Global Transdermal Drug Delivery Systems Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 33. Global Transdermal Drug Delivery Systems Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 34. North America Transdermal Drug Delivery Systems Market Size by Type (2016-2021) (US$ Million)
Table 35. North America Transdermal Drug Delivery Systems Market Size by Type (2022-2027) & (US$ Million)
Table 36. North America Transdermal Drug Delivery Systems Market Size by Application (2016-2021) (US$ Million)
Table 37. North America Transdermal Drug Delivery Systems Market Size by Application (2022-2027) & (US$ Million)
Table 38. North America Transdermal Drug Delivery Systems Market Size by Country (2016-2021) & (US$ Million)
Table 39. North America Transdermal Drug Delivery Systems Market Size by Country (2022-2027) & (US$ Million)
Table 40. Europe Transdermal Drug Delivery Systems Market Size by Type (2016-2021) (US$ Million)
Table 41. Europe Transdermal Drug Delivery Systems Market Size by Type (2022-2027) & (US$ Million)
Table 42. Europe Transdermal Drug Delivery Systems Market Size by Application (2016-2021) (US$ Million)
Table 43. Europe Transdermal Drug Delivery Systems Market Size by Application (2022-2027) & (US$ Million)
Table 44. Europe Transdermal Drug Delivery Systems Market Size by Country (2016-2021) & (US$ Million)
Table 45. Europe Transdermal Drug Delivery Systems Market Size by Country (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Transdermal Drug Delivery Systems Market Size by Type (2016-2021) (US$ Million)
Table 47. Asia-Pacific Transdermal Drug Delivery Systems Market Size by Type (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Transdermal Drug Delivery Systems Market Size by Application (2016-2021) (US$ Million)
Table 49. Asia-Pacific Transdermal Drug Delivery Systems Market Size by Application (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Transdermal Drug Delivery Systems Market Size by Region (2016-2021) & (US$ Million)
Table 51. Asia-Pacific Transdermal Drug Delivery Systems Market Size by Region (2022-2027) & (US$ Million)
Table 52. Latin America Transdermal Drug Delivery Systems Market Size by Type (2016-2021) (US$ Million)
Table 53. Latin America Transdermal Drug Delivery Systems Market Size by Type (2022-2027) & (US$ Million)
Table 54. Latin America Transdermal Drug Delivery Systems Market Size by Application (2016-2021) (US$ Million)
Table 55. Latin America Transdermal Drug Delivery Systems Market Size by Application (2022-2027) & (US$ Million)
Table 56. Latin America Transdermal Drug Delivery Systems Market Size by Country (2016-2021) & (US$ Million)
Table 57. Latin America Transdermal Drug Delivery Systems Market Size by Country (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Transdermal Drug Delivery Systems Market Size by Type (2016-2021) (US$ Million)
Table 59. Middle East & Africa Transdermal Drug Delivery Systems Market Size by Type (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Transdermal Drug Delivery Systems Market Size by Application (2016-2021) (US$ Million)
Table 61. Middle East & Africa Transdermal Drug Delivery Systems Market Size by Application (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Transdermal Drug Delivery Systems Market Size by Country (2016-2021) & (US$ Million)
Table 63. Middle East & Africa Transdermal Drug Delivery Systems Market Size by Country (2022-2027) & (US$ Million)
Table 64. Hisamitsu Company Details
Table 65. Hisamitsu Business Overview
Table 66. Hisamitsu Transdermal Drug Delivery Systems Product
Table 67. Hisamitsu Revenue in Transdermal Drug Delivery Systems Business (2016-2021) & (US$ Million)
Table 68. Hisamitsu Recent Development
Table 69. Mylan Company Details
Table 70. Mylan Business Overview
Table 71. Mylan Transdermal Drug Delivery Systems Product
Table 72. Mylan Revenue in Transdermal Drug Delivery Systems Business (2016-2021) & (US$ Million)
Table 73. Mylan Recent Development
Table 74. GSK Company Details
Table 75. GSK Business Overview
Table 76. GSK Transdermal Drug Delivery Systems Product
Table 77. GSK Revenue in Transdermal Drug Delivery Systems Business (2016-2021) & (US$ Million)
Table 78. GSK Recent Development
Table 79. Novartis Company Details
Table 80. Novartis Business Overview
Table 81. Novartis Transdermal Drug Delivery Systems Product
Table 82. Novartis Revenue in Transdermal Drug Delivery Systems Business (2016-2021) & (US$ Million)
Table 83. Novartis Recent Development
Table 84. Teve(Actavis) Company Details
Table 85. Teve(Actavis) Business Overview
Table 86. Teve(Actavis) Transdermal Drug Delivery Systems Product
Table 87. Teve(Actavis) Revenue in Transdermal Drug Delivery Systems Business (2016-2021) & (US$ Million)
Table 88. Teve(Actavis) Recent Development
Table 89. Johnson & Johnson Company Details
Table 90. Johnson & Johnson Business Overview
Table 91. Johnson & Johnson Transdermal Drug Delivery Systems Product
Table 92. Johnson & Johnson Revenue in Transdermal Drug Delivery Systems Business (2016-2021) & (US$ Million)
Table 93. Johnson & Johnson Recent Development
Table 94. UCB Company Details
Table 95. UCB Business Overview
Table 96. UCB Transdermal Drug Delivery Systems Product
Table 97. UCB Revenue in Transdermal Drug Delivery Systems Business (2016-2021) & (US$ Million)
Table 98. UCB Recent Development
Table 99. Teikoku Seiyaku Company Details
Table 100. Teikoku Seiyaku Business Overview
Table 101. Teikoku Seiyaku Revenue in Transdermal Drug Delivery Systems Business (2016-2021) & (US$ Million)
Table 102. Teikoku Seiyaku Recent Development
Table 103. Bayer Company Details
Table 104. Bayer Business Overview
Table 105. Bayer Transdermal Drug Delivery Systems Product
Table 106. Bayer Revenue in Transdermal Drug Delivery Systems Business (2016-2021) & (US$ Million)
Table 107. Bayer Recent Development
Table 108. Lingrui Company Details
Table 109. Lingrui Business Overview
Table 110. Lingrui Transdermal Drug Delivery Systems Product
Table 111. Lingrui Revenue in Transdermal Drug Delivery Systems Business (2016-2021) & (US$ Million)
Table 112. Lingrui Recent Development
Table 113. Sanofi Company Details
Table 114. Sanofi Business Overview
Table 115. Sanofi Transdermal Drug Delivery Systems Product
Table 116. Sanofi Revenue in Transdermal Drug Delivery Systems Business (2016-2021) & (US$ Million)
Table 117. Sanofi Recent Development
Table 118. Qizheng Company Details
Table 119. Qizheng Business Overview
Table 120. Qizheng Transdermal Drug Delivery Systems Product
Table 121. Qizheng Revenue in Transdermal Drug Delivery Systems Business (2016-2021) & (US$ Million)
Table 122. Qizheng Recent Development
Table 123. Endo Company Details
Table 124. Endo Business Overview
Table 125. Endo Transdermal Drug Delivery Systems Product
Table 126. Endo Revenue in Transdermal Drug Delivery Systems Business (2016-2021) & (US$ Million)
Table 127. Endo Recent Development
Table 128. Huarun 999 Company Details
Table 129. Huarun 999 Business Overview
Table 130. Huarun 999 Transdermal Drug Delivery Systems Product
Table 131. Huarun 999 Revenue in Transdermal Drug Delivery Systems Business (2016-2021) & (US$ Million)
Table 132. Huarun 999 Recent Development
Table 133. Haw Par Company Details
Table 134. Haw Par Business Overview
Table 135. Haw Par Transdermal Drug Delivery Systems Product
Table 136. Haw Par Revenue in Transdermal Drug Delivery Systems Business (2016-2021) & (US$ Million)
Table 137. Haw Par Recent Development
Table 138. Nichiban Company Details
Table 139. Nichiban Business Overview
Table 140. Nichiban Transdermal Drug Delivery Systems Product
Table 141. Nichiban Revenue in Transdermal Drug Delivery Systems Business (2016-2021) & (US$ Million)
Table 142. Nichiban Recent Development
Table 143. Mentholatum Company Company Details
Table 144. Mentholatum Company Business Overview
Table 145. Mentholatum Company Transdermal Drug Delivery Systems Product
Table 146. Mentholatum Company Revenue in Transdermal Drug Delivery Systems Business (2016-2021) & (US$ Million)
Table 147. Mentholatum Company Recent Development
Table 148. Laboratoires Genevrier Company Details
Table 149. Laboratoires Genevrier Business Overview
Table 150. Laboratoires Genevrier Transdermal Drug Delivery Systems Product
Table 151. Laboratoires Genevrier Revenue in Transdermal Drug Delivery Systems Business (2016-2021) & (US$ Million)
Table 152. Laboratoires Genevrier Recent Development
Table 153. Research Programs/Design for This Report
Table 154. Key Data Information from Secondary Sources
Table 155. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Transdermal Drug Delivery Systems Market Share by Type: 2020 VS 2027
Figure 2. Fentanyl Features
Figure 3. Nitroglycerin Features
Figure 4. Estradiol Features
Figure 5. Nicotine Features
Figure 6. Other Features
Figure 7. Global Transdermal Drug Delivery Systems Market Share by Application: 2020 VS 2027
Figure 8. OTC Case Studies
Figure 9. Rx Case Studies
Figure 10. Transdermal Drug Delivery Systems Report Years Considered
Figure 11. Global Transdermal Drug Delivery Systems Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Transdermal Drug Delivery Systems Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Transdermal Drug Delivery Systems Market Share by Regions: 2020 VS 2027
Figure 14. Global Transdermal Drug Delivery Systems Market Share by Regions (2022-2027)
Figure 15. Global Transdermal Drug Delivery Systems Market Share by Players in 2020
Figure 16. Global Top Transdermal Drug Delivery Systems Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Transdermal Drug Delivery Systems as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Transdermal Drug Delivery Systems Revenue in 2020
Figure 18. Global Transdermal Drug Delivery Systems Revenue Market Share by Type (2016-2021)
Figure 19. Global Transdermal Drug Delivery Systems Revenue Market Share by Type (2022-2027)
Figure 20. North America Transdermal Drug Delivery Systems Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Transdermal Drug Delivery Systems Market Share by Type (2016-2027)
Figure 22. North America Transdermal Drug Delivery Systems Market Share by Application (2016-2027)
Figure 23. North America Transdermal Drug Delivery Systems Market Share by Country (2016-2027)
Figure 24. United States Transdermal Drug Delivery Systems Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Transdermal Drug Delivery Systems Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Transdermal Drug Delivery Systems Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Transdermal Drug Delivery Systems Market Share by Type (2016-2027)
Figure 28. Europe Transdermal Drug Delivery Systems Market Share by Application (2016-2027)
Figure 29. Europe Transdermal Drug Delivery Systems Market Share by Country (2016-2027)
Figure 30. Germany Transdermal Drug Delivery Systems Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Transdermal Drug Delivery Systems Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Transdermal Drug Delivery Systems Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Transdermal Drug Delivery Systems Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Transdermal Drug Delivery Systems Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Transdermal Drug Delivery Systems Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Transdermal Drug Delivery Systems Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Transdermal Drug Delivery Systems Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Transdermal Drug Delivery Systems Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Transdermal Drug Delivery Systems Market Share by Region (2016-2027)
Figure 40. China Transdermal Drug Delivery Systems Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Transdermal Drug Delivery Systems Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Transdermal Drug Delivery Systems Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Transdermal Drug Delivery Systems Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Transdermal Drug Delivery Systems Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Transdermal Drug Delivery Systems Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Transdermal Drug Delivery Systems Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Transdermal Drug Delivery Systems Market Share by Type (2016-2027)
Figure 48. Latin America Transdermal Drug Delivery Systems Market Share by Application (2016-2027)
Figure 49. Latin America Transdermal Drug Delivery Systems Market Share by Country (2016-2027)
Figure 50. Mexico Transdermal Drug Delivery Systems Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Transdermal Drug Delivery Systems Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Transdermal Drug Delivery Systems Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Transdermal Drug Delivery Systems Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Transdermal Drug Delivery Systems Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Transdermal Drug Delivery Systems Market Share by Country (2016-2027)
Figure 56. Turkey Transdermal Drug Delivery Systems Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Transdermal Drug Delivery Systems Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Transdermal Drug Delivery Systems Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Hisamitsu Revenue Growth Rate in Transdermal Drug Delivery Systems Business (2016-2021)
Figure 60. Mylan Revenue Growth Rate in Transdermal Drug Delivery Systems Business (2016-2021)
Figure 61. GSK Revenue Growth Rate in Transdermal Drug Delivery Systems Business (2016-2021)
Figure 62. Novartis Revenue Growth Rate in Transdermal Drug Delivery Systems Business (2016-2021)
Figure 63. Teve(Actavis) Revenue Growth Rate in Transdermal Drug Delivery Systems Business (2016-2021)
Figure 64. Johnson & Johnson Revenue Growth Rate in Transdermal Drug Delivery Systems Business (2016-2021)
Figure 65. UCB Revenue Growth Rate in Transdermal Drug Delivery Systems Business (2016-2021)
Figure 66. Teikoku Seiyaku Revenue Growth Rate in Transdermal Drug Delivery Systems Business (2016-2021)
Figure 67. Bayer Revenue Growth Rate in Transdermal Drug Delivery Systems Business (2016-2021)
Figure 68. Lingrui Revenue Growth Rate in Transdermal Drug Delivery Systems Business (2016-2021)
Figure 69. Sanofi Revenue Growth Rate in Transdermal Drug Delivery Systems Business (2016-2021)
Figure 70. Qizheng Revenue Growth Rate in Transdermal Drug Delivery Systems Business (2016-2021)
Figure 71. Endo Revenue Growth Rate in Transdermal Drug Delivery Systems Business (2016-2021)
Figure 72. Huarun 999 Revenue Growth Rate in Transdermal Drug Delivery Systems Business (2016-2021)
Figure 73. Haw Par Revenue Growth Rate in Transdermal Drug Delivery Systems Business (2016-2021)
Figure 74. Nichiban Revenue Growth Rate in Transdermal Drug Delivery Systems Business (2016-2021)
Figure 75. Mentholatum Company Revenue Growth Rate in Transdermal Drug Delivery Systems Business (2016-2021)
Figure 76. Laboratoires Genevrier Revenue Growth Rate in Transdermal Drug Delivery Systems Business (2016-2021)
Figure 77. Bottom-up and Top-down Approaches for This Report
Figure 78. Data Triangulation
Figure 79. Key Executives Interviewed
世界の経皮パッチ薬物送達システム市場規模・現状・予測（2021年-2027年） Transdermal patches drug delivery system are a method of delivering drugs directly through the skin into the bloodstream.It mainly has polymer matrix, drug, penetration accelerator and adhesive layer.Patches can provide controlled, continuous administration of drugs that are easy to eat with minimal…- 世界の経粘膜薬物送達システム市場規模・現状・予測（2021年-2027年） The transmucosal route includes oral, nasal, vaginal, and urethral and presents a challenge in the field of novel drug delivery technology. The transmucosal membranes are relatively permeable, have a rich blood flow and hence allow the rapid uptake of a drug into systemic circulation to avoid first …
- 世界の小分子ドラッグデリバリー市場規模・現状・予測（2021年-2027年） The small molecules drugs are able to enter cells easily because of its low molecular weight. These molecules are better than monoclonal antibodies and other large molecule drugs due to their size, easy convertibility to oral form and cost affectivity. The discovery of novel small molecule entities …
- 世界のドラッグデリバリーアクロス血液脳関門市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Drug Delivery Across Blood Brain Barrier Market The global Drug Delivery Across Blood Brain Barrier market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analys…
- ニトログリセリン経皮パッチのグローバル市場調査 2019年 The global Nitroglycerin Transdermal Patches market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Nitroglycerin Transdermal Patches volume and value at global level, regional level and company level. Fro…